Science: Theoretically - New clues on Alzheimer's
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.And another gene: this one, for Alzheimer's. An American team, also writing in Nature Genetics, say the two forms (A and G) of the gene which controls production of the enzyme bleomycin hydrolase (BH) confer different risks of developing the degenerative brain disease. People with two copies of the "G" form have about twice the normal risk of developing Alzheimer's, according to the research. It's one of a handful of genes found since 1993 to be a risk factor for the disease.
So what does bleomycin hydrolase do? No one's sure. Yeasts have it, people have it, and one thing it does is inactivate a compound known as bleomycin, used in cancer chemotherapy. After that? Well, it affects your susceptibility to Alzheimer's ...
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments